LPL Financial »

Nektar Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $327k 4.6k 71.95
2025-09-30 $271k 4.8k 56.90

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPYM)
Ishares Tr Core Msci Eafe (IEFA)
Spdr Series Trust State Street Spd (SPYG)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Core Msci Emkt (IEMG)
Amazon (AMZN)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Us Treas Bd Etf (GOVT)
Ishares Tr Msci Usa Qlt Fct (QUAL)

View all positions for LPL Financial

Top funds holding Nektar Therapeutics

BVF
Two Seas Capital
Vanguard Capital Management
Susquehanna International
Vanguard Group
Two Sigma Investments
BlackRock
Citadel Advisors
Morgan Stanley
Armistice Capital
Invesco
Prosight Management
Sofinnova Ventures
Woodline Partners
Lord, Abbett & Co

View all funds holding Nektar Therapeutics